Acutus Medical Inc (AFIB) 주가 예측

Acutus Medical, Inc. is an arrhythmia management company, which engages in improving the way cardiac arrhythmias are diagnosed and treated. The company is headquartered in Carlsbad, California and currently employs 85 full-time employees. The company went IPO on 2020-08-06. The firm is solely focused on supporting the manufacturing and distribution of products to Medtronic. The company manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (i.e., the Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.